Pharmacogenomic biomarkers for prediction of severe adverse drug reactions

N Engl J Med. 2008 Feb 7;358(6):637-9. doi: 10.1056/NEJMe0708842.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Dideoxynucleosides / adverse effects*
  • Drug Hypersensitivity / diagnosis*
  • Genetic Markers
  • Genetic Testing
  • HLA-B Antigens / genetics*
  • Humans
  • Patch Tests
  • Pharmacogenetics*
  • Reverse Transcriptase Inhibitors / adverse effects*

Substances

  • Dideoxynucleosides
  • Genetic Markers
  • HLA-B Antigens
  • HLA-B*57:01 antigen
  • Reverse Transcriptase Inhibitors
  • abacavir